Company news
GENinCode PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Approval of California state license
January 3, 2023
Issue of Share Options
November 22, 2022
British Medical Journal publication
November 3, 2022
Half-year report
September 27, 2022
Notice of results
September 7, 2022
NHS implementation of Lipid inCode testing
July 26, 2022
Director Appointment
April 6, 2022
Indiana University Medical School collaboration
March 23, 2022
Lipid inCode pilot
March 15, 2022
Confirmation of board appointment
February 21, 2022
Positive results for Lipid inCode in NHS study
February 8, 2022
Proposed independent directorate appointment
January 21, 2022
FDA Pre-Submission for Cardio inCode-SCORE
January 10, 2022
Directorate Change
November 29, 2021
Grant of Share Options and PDMR dealing
September 17, 2021
Positive Thrombo inCode clinical results
July 26, 2021
Admission to trading on AIM & First Day of Dealing
July 22, 2021
Calls
The 5 newest of 10 calls. Every call is listed under its year.
- Genincode (LSE:GENI) — Full year results briefing
Jun 10, 2026
Transcript - Genincode (LSE:GENI) — Interim results presentation
Oct 2, 2025
Transcript - Genincode (LSE:GENI) — Full year results briefing
Jun 5, 2025
Transcript - Genincode (LSE:GENI) — Interim results presentation
Sep 25, 2024
Transcript - Genincode (LSE:GENI) — Full year results briefing
Jun 4, 2024
Transcript